- Info
- Insider Trading
- Financials
- Holders: SRZN, SRZN
Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN)
CUSIP: 86889P208
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 8,545,455
- Total 13F shares
- 4,842,546
- Share change
- +313,241
- Total reported value
- $62,396,754
- Price per share
- $12.88
- Number of holders
- 35
- Value change
- +$4,541,384
- Number of buys
- 15
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 86889P208?
CUSIP 86889P208 identifies SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86889P208:
Top shareholders of SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Column Group LLC |
13F
|
Company |
—
class O/S missing
|
1,499,773
|
$13,407,971 | — | 30 Jun 2025 | |
| 5AM Partners VII, LLC |
13D/G
|
— |
9.9%
|
908,387
|
$9,102,038 | $0 | 26 Mar 2025 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
9.9%
|
872,546
|
$8,742,911 | $0 | 26 Mar 2025 | |
| AI Biotechnology LLC |
13D/G
|
— |
9.9%
|
844,563
|
$8,462,521 | $0 | 24 Mar 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
8%
|
686,539
|
$6,137,659 | — | 30 Jun 2025 | |
| VR Adviser, LLC |
13F
|
Company |
7.4%
|
632,931
|
$5,658,403 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
7.1%
|
602,626
|
$5,387,476 | — | 30 Jun 2025 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
5.2%
|
455,299
|
$4,011,184 | +$1,025,211 | 30 Jun 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
3.6%
|
310,000
|
$2,771,400 | — | 30 Jun 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
3.6%
|
306,029
|
$2,735,899 | — | 30 Jun 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
3%
|
260,000
|
$2,324,400 | — | 30 Jun 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
—
mixed-class rows
|
341,399
mixed-class rows
|
$2,159,926 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
218,950
|
$1,957,413 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
1.9%
|
166,666
|
$1,669,993 | $0 | 31 Mar 2025 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
2%
|
170,000
|
$1,519,800 | — | 30 Jun 2025 | |
| BRAIDWELL LP |
13F
|
Company |
1.6%
|
140,000
|
$1,251,600 | — | 30 Jun 2025 | |
| Of The University Of California Regents |
13F
|
Individual |
—
mixed-class rows
|
216,540
mixed-class rows
|
$1,192,204 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
88,653
|
$792,558 | — | 30 Jun 2025 | |
| Euclidean Capital LLC |
13F
|
Company |
—
mixed-class rows
|
258,529
mixed-class rows
|
$787,094 | — | 30 Jun 2025 | |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
— |
2.2%
|
73,918
|
$740,658 | -$1,032,581 | 31 Mar 2025 | |
| Benny Soffer |
3/4/5
|
FORMER DIRECTOR |
—
mixed-class rows
|
2,029,667
mixed-class rows
|
$716,300 | — | 11 Aug 2021 | |
| Kevin Harold Livingston |
3/4/5
|
Former Chief Financial Officer |
—
mixed-class rows
|
2,029,667
mixed-class rows
|
$716,300 | — | 11 Aug 2021 | |
| Life Sciences Consonance |
3/4/5
|
Former 10% Holder |
—
mixed-class rows
|
2,029,667
mixed-class rows
|
$716,300 | — | 11 Aug 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
0.79%
from 13D/G
|
67,566
|
$604,040 | — | 30 Jun 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
—
class O/S missing
|
66,665
|
$595,985 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.7%
|
60,000
|
$536,400 | — | 30 Jun 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
—
mixed-class rows
|
163,456
mixed-class rows
|
$494,761 | — | 30 Jun 2025 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.61%
|
52,130
|
$466,042 | — | 30 Jun 2025 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
—
mixed-class rows
|
81,263
mixed-class rows
|
$429,094 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.41%
|
34,764
|
$310,790 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
30,963
|
$276,850 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13D/G
13F
|
Company |
0.8%
|
26,855
|
$269,087 | $0 | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
—
mixed-class rows
|
63,381
mixed-class rows
|
$196,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.18%
|
15,483
|
$138,418 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
14,626
|
$130,756 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
10,451
|
$93,432 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
833,333
|
$15,083 | — | 30 Jun 2025 | |
| Geertrui Vanhove |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
32,412
|
$12,317 | — | 15 Dec 2022 | |
| LMR Partners LLP |
13F
|
Company |
—
class O/S missing
|
648,285
|
$11,734 | — | 30 Jun 2025 | |
| Christopher Haqq |
3/4/5
|
Former Director |
—
class O/S missing
|
30,000
|
$11,400 | — | 11 Aug 2021 | |
| Donald J. Santel |
3/4/5
|
Former Director |
—
class O/S missing
|
30,000
|
$11,400 | — | 11 Aug 2021 | |
| Jennifer Jarrett |
3/4/5
|
Former Director |
—
class O/S missing
|
30,000
|
$11,400 | — | 11 Aug 2021 | |
| Yeh Wen-Chen |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
27,216
|
$10,342 | — | 15 Jun 2023 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
442,052
|
$8,001 | — | 30 Jun 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
—
class O/S missing
|
166,666
|
$3,017 | — | 30 Jun 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
281
|
$2,512 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
1,699
mixed-class rows
|
$2,341 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
216
|
$1,931 | — | 30 Jun 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
—
class O/S missing
|
70,824
|
$1,282 | — | 30 Jun 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
—
class O/S missing
|
66,666
|
$1,207 | — | 30 Jun 2025 |
Institutional Holders of Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN) as of Q3 2025
As of 30 Sep 2025,
Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,842,546 shares.
The largest 10 holders included
STEMPOINT CAPITAL LP, VR ADVISER, LLC, RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, VANGUARD GROUP INC, Vivo Capital, LLC, Stonepine Capital Management, LLC, SAMSARA BIOCAPITAL, LLC, Nantahala Capital Management, LLC, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
30
Q3 2025 holders
35
Holder diff
5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.